Ally Bridge Group (Ny) LLC Ideaya Biosciences, Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $4.81 Million - $10.3 Million	-430,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $3.06 Million - $3.92 Million	-145,940 Reduced 25.34%	430,000 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $1.13 Million - $1.77 Million	65,533 Added 12.84%	575,940 $14.7 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $8.53 Million - $11.9 Million	480,407 Added 1601.36%	510,407 $10.7 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $404,400 - $713,100	30,000 New	30,000 $705,000

212

80.3M

80.3K

30.5K

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $956M
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.